About UCLA Cardiovascular Center
"Visit the UCLA Health website for coronavirus updates."
Clinical Trials at UCLA Cardiovascular Center
During the past decade, UCLA Cardiovascular Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Cardiovascular Center"
#1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at UCLA Cardiovascular Center
According to Clinical.Site data, the most researched conditions in "UCLA Cardiovascular Center" are
"Atrial Fibrillation" (1 trials) and "Cardiomyopathy" (1 trials). Many other conditions were trialed in "UCLA Cardiovascular Center" in a lesser frequency.
Clinical Trials Intervention Types at UCLA Cardiovascular Center
Most popular intervention types in "UCLA Cardiovascular Center" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Edoxaban-based Regimen" (1 trials), "Three-lead CRT-D (Defibrillator)" (1 trials) and "VKA-based Regimen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UCLA Cardiovascular Center
The vast majority of trials in "UCLA Cardiovascular Center" are
2 trials for "All" genders.
Clinical Trials Status at UCLA Cardiovascular Center
Currently, there are NaN active trials in "UCLA Cardiovascular Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in UCLA Cardiovascular Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Cardiovascular Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".